NEWS
Xingqi 1971-2014 Milestones
Release time:2019-01-11 author:SINQI

Sinqi Commune Pharmaceutical Factory, Tiexi District, Shenyang City, the precursor of Shenyang Sinqi Ophthalmic Medications Holdings Co., Ltd., was founded on July 1, 1971

Sinqi Commune Pharmaceutical Factory was renamed Shenyang Sinqi Pharmaceutical Factory on May 9, 1980

Liu Jidong took over as deputy director of Shenyang Sinqi Pharmaceutical Factory on December 31, 1989

China’s first third-generation quinolone ciprofloxacin hydrochloride eye drops were launched on July 12, 1993

Dikeluo® Ofloxacin Eye Ointment, an ophthalmic gel innovated in China, was launched on January 19, 1994

Difei® Diclofenac Sodium Eye Drops, China’s first non-steroidal anti-inflammatory drug, was launched on January 11, 1996

Sinqi Zhangshi Factory, which was invested and founded by Sinqi Pharmaceutical Factory at the Shenyang Economic and Technological Development Zone, completed construction and started production in 1998

Pufen, anti-fungal fluconazole eye drops innovated in China, was launched on October 24, 1999

Shenyang Sinqi Pharmaceutical Factory carried out system reforms and founded Shenyang Sinqi Pharmaceutical Co., Ltd. on July 5, 2000. The company is brimming with vitality through a focus on ophthalmology and an effective management and incentive mechanism.

Juming, anti-bacterial, anti-inflammatory and anti-viral traditional Chinese medicine eye drops, was launched on October 25, 2001

Sinqi Pharmaceutical R&D Center was named to the Provincial-level Enterprise Technology Center in Liaoning Province by the Liaoning Economic Commission in 2004

Dishan, China’s first atropine sulfate eye gel, was launched on November 15, 2005

Sinqi Pharmaceutical Sunshine Charity Fund was established in 2006, through which the company actively participated in disaster relief, student assistance, poverty alleviation and many other public welfare programs.

Ziyang, China’s first fifth-generation artificial tear vitamin A palmitate eye gel, was launched on November 9, 2007

Sinqi Pharmaceutical R&D Center was renamed Liaoning Sinqi Ophthalmic Medication Engineering Technology Research Center by the Science and Technology Department of Liaoning Province in 2007

Sugaojie, China’s first de-proteinized calf blood extract eye gel, was launched on December 28, 2007

On December 16, 2008, Sinqi Pharmaceutical and the Ophthalmology Branch of the Chinese Medical Association launched the Sinqi Continuing Education Scholarship project, which set a precedent for continuing education of Chinese ophthalmologists. Sinqi Pharmaceutical subsidizes the continuing education classes of the Ophthalmology Branch of the Chinese Medical Association in the form of continuing education scholarships to promote the continuing ophthalmology education in China.

Diyou, the world’s first fourth-generation quinolone eye gel, was launched on April 9, 2009

Liu Jidong, chairman and general manager of Sinqi Pharmaceutical, personally donated RMB 1 million to found the Sinqi Charity Fund in July 2009, which was formerly known as the Sinqi Sunshine Charity Fund. The establishment of Sinqi Charity Fund marked a giant leap forward of the company in charitable undertakings.

Sinqi Pharmaceutical set about building an ophthalmic pharmacology and pharmacokinetics platform in 2010 and became the first pharmaceutical company to carry out ophthalmic pharmacological and pharmacokinetic research in China.

Sinqi completed the second restructuring on November 28, 2011, founded Shenyang Sinqi Ophthalmic Medications Holdings Co., Ltd. and appointed Liu Jidong as chairman and general manager on November 28, 2011

Shenyang Sinqi Ophthalmic Medications Holdings Co., Ltd. moved the marketing center to Beijing in July 2012

On May 13, 2013, Shenyang Sinqi Ophthalmic Medications Holdings Co., Ltd. cooperated with the Ophthalmologist Branch of the Chinese Medical Doctors Association to subsidize continuing medical education and training of outstanding resident physicians at the grassroots level to promote the development of ophthalmology at the grassroots level

Sugaojieliao, the world’s first de-proteinized calf blood extract eye drops (single dose), was launched in 2013

The Qipan Mountain Factory of Sinqi Ophthalmic Medications completed construction, passed the certification of the new version of GMP and started production in 2014. The factory involved an investment of RMB 470 million.